Dennis J. Shale
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Dennis J. Shale has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Charlotte Emma Bolton
Centre for Respiratory Research, Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK
3 shared publications A.A. Ionescu
Department of Respiratory Medicine, School of Medicine, Cardiff University, Academic Centre, Llandough Hospital, Penarth, Penlan Road, Vale of Glamorgan, CF64 2XX, UK
2 shared publicationsP.H. Edwards
2 shared publicationsT.A. Faulkner
2 shared publications- William David Evans
Department of Medical Physics, University Hospital of Wales, Cardiff, UK
2 shared publications A A Ionescu
Section of Respiratory and Communicable Diseases, Department of Medicine, University of Wales College of Medicine, Llandough Hospital, Cardiff and Vale NHS Trust, Penarth, South Glamorgan CF64 2XX, UK
1 shared publication
Latest Publications
- Open Access
Aortic Pulse Wave Velocity as a Measure of Cardiovascular Risk in Chronic Obstructive Pulmonary Disease: Two-Year Follow-Up Data from the ARCADE Study
Background and objectives: Cardiovascular (CV) disease is a major cause of morbidity and mortality in chronic obstructive pulmonary disease (COPD). Patients with COPD have increased arterial stiffness, which may predict future CV risk. However, the development of arterial stiffness in COPD has not yet been studied prospectively. The Assessment of Risk in Chronic Airways Disease Evaluation (ARCADE) is a longitudinal study of CV risk and other comorbidities in COPD. The aims of this analysis were to explore factors associated with aortic pulse wave velocity (aPWV) at baseline and to describe the progression of aPWV in patients with COPD and comparators over two years. Materials and methods: At baseline, 520 patients with COPD (confirmed by spirometry) and 150 comparators free from respiratory disease were assessed for body composition, blood pressure, aPWV, noninvasive measures of cardiac output, inflammatory biomarkers, and exercise capacity. This was repeated after two years, and mortality cases and causes were also recorded. Results: At baseline, aPWV was greater in COPD patients 9.8 (95% confidence interval (CI) 9.7–10) versus comparators 8.7 (8.5–9.1) m/s (p < 0.01) after adjustments for age, mean arterial pressure (MAP), and heart rate. Mean blood pressure was 98 ± 11 in COPD patients and 95 ± 10 mmHg in comparators at baseline (p = 0.004). After two years, 301 patients and 105 comparators were fully reassessed. The mean (95% CI) aPWV increased similarly in patients 0.44 (0.25–0.63) and comparators 0.46 (0.23–0.69) m/s, without a change in blood pressure. At the two-year follow-up, there were 29 (6%) deaths in COPD patients, with the majority due to respiratory causes, with an overall dropout of 43% of patients with COPD and 30% of comparators. Conclusions: This was the first large longitudinal study of CV risk in COPD patients, and we confirmed greater aPWV in COPD patients than comparators after adjustments for confounding factors. After two years, patients and comparators had a similar increase of almost 0.5 m/s aPWV.
Open AccessAortic Pulse Wave Velocity as a Measure of Cardiovascular Risk in Chronic Obstructive Pulmonary Disease: Two-Year Follow-Up Data from the ARCADE Study
Background and objectives: Cardiovascular (CV) disease is a major cause of morbidity and mortality in chronic obstructive pulmonary disease (COPD). Patients with COPD have increased arterial stiffness, which may predict future CV risk. However, the development of arterial stiffness in COPD has not yet been studied prospectively. The Assessment of Risk in Chronic Airways Disease Evaluation (ARCADE) is a longitudinal study of CV risk and other comorbidities in COPD. The aims of this analysis were to explore factors associated with aortic pulse wave velocity (aPWV) at baseline and to describe the progression of aPWV in patients with COPD and comparators over two years. Materials and methods: At baseline, 520 patients with COPD (confirmed by spirometry) and 150 comparators free from respiratory disease were assessed for body composition, blood pressure, aPWV, noninvasive measures of cardiac output, inflammatory biomarkers, and exercise capacity. This was repeated after two years, and mortality cases and causes were also recorded. Results: At baseline, aPWV was greater in COPD patients 9.8 (95% confidence interval (CI) 9.7–10) versus comparators 8.7 (8.5–9.1) m/s (p < 0.01) after adjustments for age, mean arterial pressure (MAP), and heart rate. Mean blood pressure was 98 ± 11 in COPD patients and 95 ± 10 mmHg in comparators at baseline (p = 0.004). After two years, 301 patients and 105 comparators were fully reassessed. The mean (95% CI) aPWV increased similarly in patients 0.44 (0.25–0.63) and comparators 0.46 (0.23–0.69) m/s, without a change in blood pressure. At the two-year follow-up, there were 29 (6%) deaths in COPD patients, with the majority due to respiratory causes, with an overall dropout of 43% of patients with COPD and 30% of comparators. Conclusions: This was the first large longitudinal study of CV risk in COPD patients, and we confirmed greater aPWV in COPD patients than comparators after adjustments for confounding factors. After two years, patients and comparators had a similar increase of almost 0.5 m/s aPWV.
- 1 May 2008
- Published by Elsevier in Respiratory Medicine
- Vol. 102 (5) , 651-657
What community measurements can be used to predict bone disease in patients with COPD?
- 1 May 2008
- Published by Elsevier in Respiratory Medicine
- Vol. 102 (5) , 651-657
What community measurements can be used to predict bone disease in patients with COPD?
- 1 April 2005
- Published by Elsevier in Respiratory Medicine
- Vol. 99 (4) , 493-500
Attaining a correct diagnosis of COPD in general practice
- 1 April 2005
- Published by Elsevier in Respiratory Medicine
- Vol. 99 (4) , 493-500
Attaining a correct diagnosis of COPD in general practice
- 1 December 2004
- Published by Wolters Kluwer Health in Cardiopulmonary Physical Therapy Journal
- Vol. 15 (4) , 23-24
Inspiratory Muscle Training Improves Lung Function and Exercise Capacity in Adults with Cystic Fibrosis.
- 1 December 2004
- Published by Wolters Kluwer Health in Cardiopulmonary Physical Therapy Journal
- Vol. 15 (4) , 23-24
Inspiratory Muscle Training Improves Lung Function and Exercise Capacity in Adults with Cystic Fibrosis.
- Open Access
Altered tissue distribution in adults with cystic fibrosis
Background: Regional body composition was determined in adults with cystic fibrosis (CF). Our hypothesis was that dual energy x ray absorptiometry (DXA) scanning could assess the fat free mass, bone mineral content, and fat mass and determine the distribution of the changes. Method: Height squared indices were derived for fat mass (FMI), fat free mass (FFMI), and bone mineral content (BMCI) of the arm, leg, and trunk by DXA in 51 patients and 18 age/sex matched healthy subjects. Results: The arm and leg FFMI in patients were less than in healthy controls (parm>trunk (−18.19%, −14.86%, +0.09%, ptrunk was shown; BMC loss was evenly distributed.
Open AccessAltered tissue distribution in adults with cystic fibrosis
Background: Regional body composition was determined in adults with cystic fibrosis (CF). Our hypothesis was that dual energy x ray absorptiometry (DXA) scanning could assess the fat free mass, bone mineral content, and fat mass and determine the distribution of the changes. Method: Height squared indices were derived for fat mass (FMI), fat free mass (FFMI), and bone mineral content (BMCI) of the arm, leg, and trunk by DXA in 51 patients and 18 age/sex matched healthy subjects. Results: The arm and leg FFMI in patients were less than in healthy controls (parm>trunk (−18.19%, −14.86%, +0.09%, ptrunk was shown; BMC loss was evenly distributed.